Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Relay Therapeutics Inc. Common Stock (RLAY) vs Vanguard Tax Managed Fund FTSE Developed Markets ETF (VEA) Price & Performance

Relay Therapeutics Inc. Common StockTrade
Vanguard Tax Managed Fund FTSE Developed Markets ETFTrade

Price performance (Past 24H)

Key statistics

Relay Therapeutics Inc. Common Stock vs Vanguard Tax Managed Fund FTSE Developed Markets ETF — how do they compare? Relay Therapeutics Inc. Common Stock trades at $17.5 (market cap $3.94B), while Vanguard Tax Managed Fund FTSE Developed Markets ETF trades at $70.47 (market cap $323.80B). The key difference: Vanguard Tax Managed Fund FTSE Developed Markets ETF is far larger — about 82.2× Relay Therapeutics Inc. Common Stock's market cap, and Vanguard Tax Managed Fund FTSE Developed Markets ETF is more actively traded (9,762,021 versus 3,432,928). Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and Vanguard Tax Managed Fund FTSE Developed Markets ETF for 131 Days on average.

RLAYVEA
Market Cap
$3.94B$323.80B
Volume
3,432,9289,762,021
Sector
Health—
52-Week High
$20.75$73.79
52-Week Low
$6.03$58.90
Typical Hold Time
0 Days131 Days
Enterprise Value
$3.06B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Relay Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Vanguard Tax Managed Fund FTSE Developed Markets ETF

VEA, the Vanguard FTSE Developed Markets ETF, trades at $70.26, down 1.2% on the day amid a bearish technical signal. The ETF provides cost-efficient exposure to developed markets outside the U.S., with a 0.03% expense ratio and competitive dividend yield. Recent news highlights institutional activity, with firms like Allianz Asset Management increasing stakes while others trimmed positions.

The outlook remains mixed, with technical indicators signaling caution but fundamental strengths in low costs and diversification. Key risks include global market volatility and currency fluctuations. Investors should weigh the ETF's stable, income-oriented profile against near-term bearish momentum.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RLAY
100% Buy0% Sell
Avg holding period · 0 Days
VEA
86% Buy14% Sell
Avg holding period · 131 Days

About Relay Therapeutics Inc. Common Stock

Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.

Read more on RLAY →

About Vanguard Tax Managed Fund FTSE Developed Markets ETF

The fund employs an indexing investment approach designed to track the performance of the FTSE Developed All Cap ex US Index, a market-capitalization-weighted index that is made up of approximately 4022 common stocks of large-, mid-, and small-cap companies located in Canada and the major markets of Europe and the Pacific region. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.

Read more on VEA →